Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2576036 | The American Journal of Geriatric Pharmacotherapy | 2007 | 9 Pages |
Abstract
Conclusions: Patients with higher levels of agitation receiving divalproex had reduced agitation on the physical aggression subscale of the CMAI. Divalproex was less effective on physically nonaggressive behavior and verbal agitation. Irritability, as measured on the NPI-NH, was also reduced. Patients who received both divalproex and an antipsychotic agent were responsive at lower doses of divalproex. In either case, the effective dosage of divalproex was lower than that commonly used for epilepsy or mania in elderly patients. The most common adverse events included somnolence and gait disturbance. (Am J Geriatr Pharmacother. 2007;5:209-217).
Related Topics
Health Sciences
Medicine and Dentistry
Geriatrics and Gerontology
Authors
Brent MD, Mark MD, Joan PhD, Rosa MEd, Calixte MA, William MS, Lesley RN,